# Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

> **NCT00095472** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 18 (actual)

## Conditions studied

- Sickle Cell Anemia

## Interventions

- **DRUG:** L-NMMA
- **DRUG:** Sodium Nitrite

## Key facts

- **NCT ID:** NCT00095472
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-01
- **Primary completion:** 2007-08-24
- **Final completion:** 2007-08-24
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095472, "Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00095472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*